These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 32341239)

  • 21. From Gleason to International Society of Urological Pathology (ISUP) grading of prostate cancer.
    Samaratunga H; Delahunt B; Yaxley J; Srigley JR; Egevad L
    Scand J Urol; 2016 Oct; 50(5):325-9. PubMed ID: 27415753
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Implications of the International Society of Urological Pathology modified Gleason grading system.
    Egevad L; Mazzucchelli R; Montironi R
    Arch Pathol Lab Med; 2012 Apr; 136(4):426-34. PubMed ID: 22458905
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Personalized urooncology based on molecular uropathology: part 1: what is diagnostic routine?].
    Stöhr CG; Stöhr R; Rogler A; Amann K; Knüchel-Clarke R; Hartmann A
    Urologe A; 2013 Jul; 52(7):970-5. PubMed ID: 23801163
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Current and proposed molecular diagnostics in a genitourinary service line laboratory at a tertiary clinical institution.
    Udager AM; Alva A; Mehra R
    Cancer J; 2014; 20(1):29-42. PubMed ID: 24445763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A novel nomogram to identify candidates for active surveillance amongst patients with International Society of Urological Pathology (ISUP) Grade Group (GG) 1 or ISUP GG2 prostate cancer, according to multiparametric magnetic resonance imaging findings.
    Luzzago S; de Cobelli O; Cozzi G; Peveri G; Bagnardi V; Catellani M; Di Trapani E; Mistretta FA; Pricolo P; Conti A; Alessi S; Marvaso G; Ferro M; Matei DV; Renne G; Jereczek-Fossa BA; Petralia G; Musi G
    BJU Int; 2020 Jul; 126(1):104-113. PubMed ID: 32150328
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Validation of International Society of Urological Pathology (ISUP) grading for prostatic adenocarcinoma in thin core biopsies using TROG 03.04 'RADAR' trial clinical data.
    Delahunt B; Egevad L; Srigley JR; Steigler A; Murray JD; Atkinson C; Matthews J; Duchesne G; Spry NA; Christie D; Joseph D; Attia J; Denham JW
    Pathology; 2015 Oct; 47(6):520-5. PubMed ID: 26325671
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Position paper on urological oncology. Joint statement of the German Society for Urology, the Professional Association of German Urologists and the Working Group Urological Oncology of the German Cancer Society].
    Hakenberg OW; Schroeder A; Gschwend J; Müller B; Köhrmann KU; Göckel-Beining B; Fichtner J; Krege S; Steffens J
    Urologe A; 2011 Sep; 50 Suppl 1():165-9. PubMed ID: 21863407
    [No Abstract]   [Full Text] [Related]  

  • 28. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Bladder Consensus Conference Committee.
    Epstein JI; Amin MB; Reuter VR; Mostofi FK
    Am J Surg Pathol; 1998 Dec; 22(12):1435-48. PubMed ID: 9850170
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Advances in uro-oncology "OncoForum": the best of 2010].
    Gómez-Veiga F; Alcaraz-Asensio A; Burgos-Revilla J; Cózar-Olmo JM
    Actas Urol Esp; 2011 Jun; 35(6):315-24. PubMed ID: 21453988
    [TBL] [Abstract][Full Text] [Related]  

  • 30. International Society of Urological Pathology (ISUP) Consensus Conference on Current Issues in Bladder Cancer: Working Group 3: Subcategorization of T1 Bladder Cancer.
    Lopez-Beltran A; Raspollini MR; Hansel D; Compérat E; Williamson SR; Liedberg F; Iczkowski KA; Bubendorf L; van der Kwast TH; Cheng L;
    Am J Surg Pathol; 2024 Jan; 48(1):e24-e31. PubMed ID: 37737692
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Re: Best practices recommendations in the application of immunohistochemistry in testicular tumors: report from the International Society of Urological Pathology Consensus Conference.
    Richie JP
    J Urol; 2015 May; 193(5):1544. PubMed ID: 25895770
    [No Abstract]   [Full Text] [Related]  

  • 32. Best practices recommendations in the application of immunohistochemistry in the prostate: report from the International Society of Urologic Pathology consensus conference.
    Epstein JI; Egevad L; Humphrey PA; Montironi R;
    Am J Surg Pathol; 2014 Aug; 38(8):e6-e19. PubMed ID: 25029122
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Contemporary prognostic indicators for prostate cancer incorporating International Society of Urological Pathology recommendations.
    Egevad L; Delahunt B; Kristiansen G; Samaratunga H; Varma M
    Pathology; 2018 Jan; 50(1):60-73. PubMed ID: 29199015
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Renal tumors: The International Society of Urologic Pathology (ISUP) 2012 consensus conference recommendations].
    Rioux-Leclercq N; Ferran A; Mahul A; Argani P; Billis A; Bonsib S; Cheng L; Cheville J; Eble J; Egevad L; Epstein J; Grignon D; Hes O; Humphrey P; Magi-Galluzzi C; Martignoni G; McKenney J; Merino M; Moch H; Montironi R; Netto G; Reuter V; Samaratunga H; Shen S; Srigley J; Tamboli P; Tan PH; Tickoo S; Trpkov K; Zhou M; Delahunt B; Comperat E;
    Ann Pathol; 2014 Dec; 34(6):448-61. PubMed ID: 25499860
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Molecular biology advances and perspectives in urology].
    Feria Bernal G; Arroyo Kuribreña JC
    Rev Invest Clin; 2003; 55(2):243-7. PubMed ID: 12827935
    [No Abstract]   [Full Text] [Related]  

  • 36. [Pathological advances in renal, prostatic, bladder and testis neoplasia].
    Rioux-Leclercq N; Comperat E; Kammerer-Jacquet SF; Camparo P; Fromont G;
    Prog Urol; 2016 Jun; 26(8):477-83. PubMed ID: 27473787
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Genitourinary Tumors: Update on Molecular Biomarkers for Diagnosis, Prognosis and Prediction of Response to Therapy.
    Cimadamore A; Scarpelli M; Santoni M; Massari F; Tartari F; Cerqueti R; Lopez-Beltran A; Cheng L; Montironi R
    Curr Drug Metab; 2019; 20(4):305-312. PubMed ID: 30799789
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Overcoming tumor heterogeneity in the molecular diagnosis of urological cancers.
    Donovan MJ; Cordon-Cardo C
    Expert Rev Mol Diagn; 2014 Nov; 14(8):1023-31. PubMed ID: 25327491
    [TBL] [Abstract][Full Text] [Related]  

  • 39. SOCS3 Immunohistochemical Expression Seems to Support the 2005 and 2014 International Society of Urological Pathology (ISUP) Modified Gleason Grading System.
    Pierconti F; Martini M; Cenci T; Petrone GL; Ricci R; Sacco E; Bassi PF; Larocca LM
    Prostate; 2017 May; 77(6):597-603. PubMed ID: 28144985
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Uropathology].
    Hartmann A; Knüchel-Clarke R; Kristiansen G
    Pathologe; 2016 Feb; 37(1):1-2. PubMed ID: 26821327
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.